A phase I randomized, open-label, 4-period, 4-sequence, crossover study investigating pharmacokinetic profile of multiple doses of co crystal of Tramadol-Celecoxib in healthy male and female volunteers

Trial Profile

A phase I randomized, open-label, 4-period, 4-sequence, crossover study investigating pharmacokinetic profile of multiple doses of co crystal of Tramadol-Celecoxib in healthy male and female volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Sep 2017

At a glance

  • Drugs Celecoxib/tramadol (Primary)
  • Indications Acute pain; Dental pain; Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Sep 2017 Results published in the British Journal of Clinical Pharmacology
    • 21 Nov 2016 New trial record
    • 30 Sep 2016 Results presented at the 16th World Congress on Pain
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top